Evidence map›Paper›PMID 27036911›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

The C-Terminal Acidic Region of Calreticulin Mediates Phosphatidylserine Binding and Apoptotic Cell Phagocytosis.

Sanjeeva Joseph Wijeyesakere, Sukhmani Kaur Bedi, David Huynh, Malini Raghavan

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Calreticulin as a marker and therapeutic target for cancer.Clinical and experimental medicine · 2023
    Review
  10. Review
  11. Article
  12. Dynamics of phagocytosis mediated by phosphatidylserine.Biochemical Society transactions · 2022
    Review
  13. Immunization withTropical medicine and infectious disease · 2022
    Article
  14. Review
  15. Article
  16. Immune evasion by cancer stem cells.Regenerative therapy · 2021
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sanjeeva Joseph Wijeyesakere *Department of Microbiology and Immunology, University of Michigan School of Medicine, Ann Arbor MI 48109.
Sukhmani Kaur Bedi *Department of Microbiology and Immunology, University of Michigan School of Medicine, Ann Arbor MI 48109.
David HuynhDepartment of Microbiology and Immunology, University of Michigan School of Medicine, Ann Arbor MI 48109.
Malini RaghavanDepartment of Microbiology and Immunology, University of Michigan School of Medicine, Ann Arbor MI 48109.
University of Michigan · US

Funding

PUBLIC HEALTH DEMONSTRATIONP60DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYERS, MARTIN G · 1985 to 2012
$26.5M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
INTERACTIONS &MECHANISMS OF FUNCTION OF THE TAP COMPLEXR01AI044115 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MALINI RAGHAVAN · 1999 to 2026
$9.3M
Calreticulin-mediated protein folding in health and diseaseR01AI123957 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAGHAVAN, MALINI · 2016 to 2025
$3.7M
Calreticulin's functions in the adaptive immune responseR01AI066131 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAGHAVAN, MALINI · 2007 to 2010
$1.7M
NIAID NIH HHS R01 AI044115NIAID NIH HHS R01 AI066131NIAID NIH HHS R01 AI123957NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P60 DK020572
6 · The paper itself

Abstract

Calreticulin is a calcium-binding chaperone that is normally localized in the endoplasmic reticulum. Calreticulin is detectable on the surface of apoptotic cells under some apoptosis-inducing conditions, where it promotes the phagocytosis and immunogenicity of dying cells. However, the precise mechanism by which calreticulin, a soluble protein, localizes to the outer surface of the plasma membrane of dying cells is unknown, as are the molecular mechanisms that are relevant to calreticulin-induced cellular phagocytosis. Calreticulin comprises three distinct structural domains: a globular domain, an extended arm-like P-domain, and a C-terminal acidic region containing multiple low-affinity calcium binding sites. We show that calreticulin, via its C-terminal acidic region, preferentially interacts with phosphatidylserine (PS) compared with other phospholipids and that this interaction is calcium dependent. Additionally, exogenous calreticulin binds apoptotic cells via a higher-affinity calcium-dependent mode that is acidic region dependent. Exogenous calreticulin also binds live cells, including macrophages, via a second, lower-affinity P-domain and globular domain-dependent, but calcium-independent binding mode that likely involves its generic polypeptide binding site. Truncation constructs lacking the acidic region or arm-like P-domain of calreticulin are impaired in their abilities to induce apoptotic cell phagocytosis by murine peritoneal macrophages. Taken together, the results of this investigation provide the first molecular insights into the phospholipid binding site of calreticulin as a key anchor point for the cell surface expression of calreticulin on apoptotic cells. These findings also support a role for calreticulin as a PS-bridging molecule that cooperates with other PS-binding factors to promote the phagocytosis of apoptotic cells.

Indexed as

CytophagocytosisAnimalsApoptosisCalreticulinCells, CulturedEndoplasmic ReticulumFemaleMacrophages, PeritonealMaleMiceMice, Inbred C57BLMice, Inbred DBAPeptide FragmentsPhosphatidylserinesProtein BindingCalreticulinPeptide FragmentsPhosphatidylserines

Identifiers

PMID27036911
PMCPMC5222549
OpenAlexW2329608768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.